Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

CMAJ. 2005 May 24;172(11):1457-9. doi: 10.1503/cmaj.1041100.

Authors

Gideon Koren¹, Doreen Matsui, Adrienne Einarson, David Knoppert, Meir Steiner

Affiliation

¹ Motherisk Program, The Hospital for Sick Children and University of Toronto, Toronto, Ont. [email protected]

No abstract available

Publication types

Review

MeSH terms

Adult
Depression / drug therapy*
Drug Administration Schedule
Evidence-Based Medicine
Female
Humans
Infant, Newborn
Maternal-Fetal Exchange
Neonatal Abstinence Syndrome
Pregnancy
Pregnancy Complications / drug therapy*
Pregnancy Complications / psychology*
Pregnancy Trimester, Third
Risk Factors
Selective Serotonin Reuptake Inhibitors / adverse effects*
Selective Serotonin Reuptake Inhibitors / pharmacology
Selective Serotonin Reuptake Inhibitors / therapeutic use

Substances

Serotonin Uptake Inhibitors